期刊
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY
卷 24, 期 5, 页码 683-693出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.bpg.2010.07.003
关键词
Alcoholic hepatitis; Acetaldehyde; Corticosteroids; Endotoxins; Enteral nutrition; Liver failure; Liver transplantation; Pentoxifylline; Tumour necrosis factor
资金
- Dietmar Hopp and Manfred Lautenschlager Foundation
- European Research Advisory Board (ERAB)
Severe alcoholic steatohepatitis has a poor prognosis and is characterized by jaundice and signs of liver failure Its incidence is unknown but prevalence is around 20% in cohorts of alcoholics undergoing liver biopsy Diagnosis is established with elevated liver transaminases neutrophil counts serum bilirubin and impaired coagulation and a history of excessive alcohol consumption and exclusion of other etiologies Histology is helpful but not mandatory Prognostic scores include the Maddrey s discriminant function the model of end-stage liver disease and the Glasgow Alcoholic Hepatitis Score Pathophysiology involves hepatic fat storage increased hepatic uptake of gut-derived endotoxins triggering Kupffer cell activation and release of proinflammatory triggers induction of cytochrome P4502E1 producing toxic acetaldehyde and reactive oxygen species and ethanol-mediated hyperhomocysteinemia causing endoplasmic reticulum stress Treatment includes abstinence enteral nutrition corticosteroids and possibly pentoxifylline A debate is ongoing whether certain patients with severe alcoholic steatohepatitis could be eligible for liver transplantation (C) 2010 Elsevier Ltd All rights reserved
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据